Tayar E, Kodali D. Delayed-onset vitiligo in metastatic HR+/HER2– breast cancer during long-term ribociclib therapy. EJCRIM [Internet]. 2025 Dec. 23 [cited 2026 Nov. 3];13(1). Available from: https://ejcrim.com/index.php/ejcrim/article/view/6043